background
advanc
molecular
diagnost
implic
newlydiscov
respiratori
virus
pathogenesi
pneumonia
aim
determin
preval
clinic
characterist
human
bocaviru
hbov
human
rhinoviru
hrv
polyomaviruswu
wupyv
ki
kipyv
human
coronavirus
cov
among
children
hospit
lower
respiratori
tract
infect
lrti
method
multiplex
realtim
reversetranscriptas
polymeras
chain
reaction
undertaken
archiv
nasopharyng
aspir
hivinfect
uninfect
children
year
age
hospit
lrti
previous
investig
respiratori
syncyti
viru
human
metapneumoviru
parainfluenza
iiii
adenoviru
influenza
ab
result
least
one
virus
identifi
lrtiepisod
hivinfect
uninfect
children
respect
human
rhinoviru
preval
hivinfect
anduninfect
children
follow
hbov
hivinfect
hbov
wupyv
hivuninfect
children
polyomaviruski
vs
p
vs
p
preval
hivinfect
uninfect
children
combin
previouslytest
virus
respiratori
virus
identifi
hivinfect
hivuninfect
children
newli
test
virus
detect
high
frequenc
associ
respiratori
virus
includ
previouslyinvestig
virus
hivinfect
hivuninfect
children
establish
combin
previouslyinvestig
virus
least
one
respiratori
viru
identifi
major
hivinfect
hivuninfect
children
hospit
lrti
high
frequenc
viral
coinfect
illustr
complex
attribut
causal
specif
virus
aetiolog
lrti
may
indic
synerget
role
viral
coinfect
pathogenesi
childhood
lrti
pneumonia
lead
caus
mortal
children
year
age
worldwid
includ
hivinfect
children
aetiolog
childhood
pneumonia
may
includ
infect
bacteria
andor
respiratori
virus
although
respiratori
virus
frequent
identifi
bacteria
children
pneumonia
may
bias
lack
avail
sensit
specif
test
diagnos
bacteri
caus
pneumonia
furthermor
respiratori
viral
infect
may
heighten
suscept
develop
superimpos
bacteri
infect
result
sever
pneumonia
tradit
respiratori
virus
associ
lower
respiratori
tract
infect
lrti
includ
respiratori
syncyti
viru
rsv
parainfluenza
virus
iiii
piv
iiii
influenza
virus
ab
adenoviru
two
human
coronavirus
cov
initi
identifi
caus
upper
respiratori
tract
infect
urti
use
classic
cultur
method
recent
advanc
molecular
diagnost
result
discoveri
respiratori
virus
also
associ
lrti
includ
among
human
metapneumoviru
hmpv
human
bocaviru
hbov
human
coronaviru
wu
ki
polyomavirus
wupyv
kipyv
also
human
rhinoviru
hrv
previous
mainli
associ
mild
urti
increasingli
implic
role
pathogenesi
lrti
asthma
exacerb
due
impair
humor
cellmedi
immun
hiv
infect
children
describ
risk
factor
sever
ill
mortal
caus
respiratoryvir
associ
lrti
rsv
hmpv
influenza
viru
howev
limit
data
role
respiratori
virus
includ
recentlydiscov
virus
occur
singl
coinfect
pathogen
hivinfect
children
hospit
lrti
studi
small
sampl
size
aim
studi
identifi
preval
hbov
hrv
wupyv
kipyv
among
hivinfect
uninfect
children
hospit
lrti
use
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
studycohort
previous
investig
rsv
influenza
ab
piv
iiii
adenoviru
immunofluoresc
assay
hmpv
nestedpcr
describ
main
pneumococc
conjug
vaccin
efficaci
trial
subsequ
retrospect
analysi
studi
particip
approv
human
research
ethic
committe
medic
univers
witwatersrand
main
studi
clinic
trial
number
sinc
undertaken
prior
registr
clinic
trial
made
mandatori
sign
inform
consent
obtain
parentleg
guardian
studi
particip
part
main
trial
ethic
committe
requir
addit
consent
studi
retrospect
studi
children
particip
phase
iii
trial
south
africa
investig
efficaci
describ
briefli
children
recruit
march
octob
random
receiv
dose
either
placebo
vaccin
occur
mean
standard
deviat
week
age
hospitalbas
surveil
allcaus
hospit
undertaken
chri
hanibaragwanath
hospit
public
hospit
studi
commun
hospit
children
sign
symptom
record
underw
hiv
test
accord
studi
protocol
nasopharyng
aspir
npa
obtain
respiratori
viral
studi
children
hospit
lrti
archiv
januari
onward
present
studi
npa
collect
st
februari
st
januari
children
less
year
old
analys
child
recurr
lrti
hospit
npa
collect
least
day
apart
includ
analysi
blood
cultur
perform
use
autom
bloodcultur
system
bactalert
organon
teknika
total
nucleic
acid
extract
archiv
npa
use
nuclisen
easymag
platform
biomerieux
elut
final
volum
ml
elut
buffer
rna
revers
transcrib
high
capac
cdna
revers
transcriptas
invitrogen
life
technolog
prime
oligodt
primer
invitrogen
life
technolog
realtim
pcr
done
abi
rtpcr
system
appli
biosystem
life
technolog
reaction
perform
ml
use
taqman
univers
pcr
master
mix
appli
biosystem
life
technolog
primer
probe
list
tabl
five
duplex
rtpcr
reaction
target
respiratori
virus
develop
intern
control
human
gene
ribonucleoprotein
dehydrogenas
spike
virus
lambda
newcastl
diseas
viru
includ
check
effici
extract
step
detect
presenc
pcr
inhibitor
posit
control
includ
experi
clinic
definit
use
studi
previous
describ
briefli
lrti
defin
episod
clinic
diagnosi
pneumonia
bronchiol
done
studi
physician
children
lrti
categor
clinic
pneumonia
evid
alveolar
consolid
chest
xray
cxrac
fulfil
clinic
diagnosi
lrti
without
wheez
chest
auscult
rale
bronchial
breath
children
categor
bronchiol
presenc
wheez
chest
auscult
absenc
document
cxrac
bronchial
breath
chest
wall
auscult
clinic
diagnosi
severeveri
sever
pneumonia
made
child
cough
day
durat
lower
chest
wall
indraw
andor
follow
sign
symptom
sever
pneumonia
feed
difficulti
convuls
central
cyanosi
encephalopathi
previous
develop
respiratori
index
sever
children
risc
score
use
compar
diseas
sever
singl
multipl
viral
infect
demograph
clinic
laboratori
characterist
admiss
compar
hivinfect
uninfect
children
chisquar
fisher
exact
test
use
compar
distribut
categor
variabl
mean
median
continu
variabl
compar
twotail
student
ttest
mannwhitney
test
respect
viral
preval
compar
hiv
group
clinic
laboratori
characterist
compar
episod
singl
multipl
viral
detect
use
multivari
logist
regress
model
adjust
studi
intervent
arm
ie
whether
receiv
placebo
year
sampl
detect
viru
previouslytest
age
result
present
adjust
odd
ratio
aor
confid
interv
ci
pvalu
pvalu
consid
signific
analys
perform
use
stata
version
statacorp
texa
usa
followup
period
includ
analysi
total
hospit
lrti
includ
npa
collect
initi
collect
sampl
avail
rtpcr
analysi
proport
sampl
avail
rtpcr
placeborecipi
p
hivinfect
vs
p
hivuninfect
children
vs
p
children
npa
avail
rtpcr
test
compar
sampl
unavail
older
median
age
vs
month
less
like
test
posit
one
previouslytest
respiratori
virus
vs
higher
preval
cyanosi
vs
p
higher
evid
cxrac
vs
p
higher
creactiv
protein
crp
level
median
vs
mgl
p
higher
procalcitonin
pct
concentr
median
vs
ngml
p
tabl
demograph
clinic
laboratori
differ
observ
lrtiepisod
npa
avail
versu
unavail
rtpcr
total
npa
sampl
hivinfect
children
analys
rtpcr
includ
placeborecipi
among
hivuninfect
children
specimen
avail
rtpcr
analysi
includ
placeborecipi
admiss
hivinfect
children
compar
hivuninfect
younger
median
age
vs
month
p
frequent
present
cyanosi
vs
lower
mean
oxygen
satur
vs
higher
median
respiratori
rate
vs
breath
per
minut
like
present
pneumonia
vs
bronchiol
higher
crp
vs
mgl
p
pct
level
vs
ngml
longer
hospit
stay
vs
median
day
p
higher
casefat
rate
vs
frequent
bacteraemia
vs
tabl
specimen
analys
hivinfect
hivuninfect
children
previous
test
hmpv
nestedpcr
test
immunofluoresc
assay
rsv
found
neg
test
influenza
ab
piv
iiii
adenoviru
describ
among
hivinfect
children
rtpcr
viral
panel
posit
lrtiepisod
least
one
newlytest
virus
tabl
preval
newlytest
respiratori
virus
similar
placeborecipi
hivinfect
children
except
wupyv
vs
p
respect
hbov
vs
p
respect
tabl
hivinfect
children
hrv
frequent
detect
viru
follow
hbov
kipyv
wupyv
tabl
newlytest
virus
frequent
identifi
coinfect
virus
among
hivinfect
children
includ
lrtiepisod
associ
hrv
tabl
common
viral
coinfect
hrv
includ
kipyv
wupyv
hbov
tabl
among
children
blood
cultur
done
bacteria
isol
occas
associ
concomit
detect
one
newlytest
virus
virus
hivuninfect
children
least
one
newlytest
viru
detect
lrtiepisod
hrv
also
common
follow
hbov
wupyv
kipyv
tabl
compar
hivuninfect
placebo
recipi
differ
preval
newlytest
virus
evid
kipyv
vs
vs
p
vs
p
hrv
vs
p
tabl
lrtiepisod
hrv
identifi
least
one
viru
detect
includ
rsv
wupyv
hbov
n
wupyv
hbov
tabl
preval
bacteraemia
hivuninfect
children
among
blood
cultur
result
n
occur
presenc
infect
one
newlytest
virus
presenc
studi
virus
multivari
analysi
adjust
pcvvaccin
statu
period
collect
age
singl
infect
newlytest
viru
frequent
hivinfect
hivuninfect
children
adjust
odd
ratio
aor
p
tabl
also
hivinfect
compar
hivuninfect
children
higher
preval
kipyv
aor
tabl
number
specimen
analys
current
studi
total
specimen
collect
compar
lrtiepisod
associ
identif
singl
viru
detect
multipl
virus
hivinfect
children
significantli
associ
higher
frequenc
bronchial
breath
aor
p
hivuninfect
children
higher
preval
cyanosi
aor
p
wheez
aor
p
tabl
differ
detect
sever
lrtiepisod
singl
multipl
viral
infect
use
risc
score
previous
develop
hivinfect
uninfect
children
bacteria
isol
blood
signific
differ
clinic
laboratori
characterist
children
virus
detect
children
without
viru
detect
observ
restrict
analysi
streptococcu
pneumonia
isol
data
shown
knowledg
studi
provid
indepth
analysi
preval
hrv
newlydiscov
respiratori
virus
hivinfect
children
studi
identifi
hrv
frequent
detect
viru
hivinfect
uninfect
children
follow
hivinfect
hbov
hivuninfect
case
hospit
associ
singl
infect
overal
note
hrv
rsv
rate
coinfect
high
children
infect
newlydiscov
virus
previouslytest
immunofluoresc
assay
previouslytest
nest
pcr
includ
virus
previouslytest
immunofluoresc
assay
rsv
influenza
piv
iiii
adenoviru
nestedpcr
hmpv
multipl
infect
includ
least
one
newlytest
viru
except
hivuninfect
children
viral
coinfect
least
one
newlytest
viru
hivinfect
children
hivuninfect
children
adjust
detect
virus
previouslytest
previouslytest
immunofluoresc
assay
previouslytest
previous
nestedpcr
includ
virus
previouslytest
immunofluoresc
assay
influenza
rsv
piv
adenoviru
nestedpcr
hmpv
patient
specimen
avail
cultur
bacteria
isol
includ
hbov
escherichia
coli
n
salmonella
sp
n
wupyv
streptococcu
pneumonia
n
escherichia
coli
n
kipyv
streptococcu
pneumonia
n
escherichia
coli
n
haemophilu
parainfluenza
n
streptococcu
pneumonia
n
escherichia
coli
n
salmonella
sp
n
streptococcu
viridan
n
streptococcu
n
hrv
streptococcu
pneumonia
n
escherichia
coli
n
streptococcu
viridan
n
citrobact
freundii
n
hmpv
salmonella
sp
n
piv
streptococcu
viridan
n
influenza
streptococcu
pneumonia
n
escherichia
coli
n
adenoviru
pseudomona
aeruginosa
n
tabl
respiratori
virus
coinfect
hivuninfect
children
hospit
lower
respiratori
tract
infect
previouslytest
immunofluoresc
assay
previouslytest
previous
nestedpcr
includ
previouslytest
immunofluoresc
assay
influenza
rsv
piv
adenoviru
nestedpcr
hmpv
viral
aetiolog
studi
conduct
africa
mozambican
studi
virusassoci
acut
respiratori
infect
ari
infant
estim
hiv
preval
frequent
detect
virus
hrv
influenza
adenoviru
recent
studi
south
africa
children
ari
requir
medic
attent
n
hivinfect
hivseroposit
also
report
hrv
frequent
detect
viru
follow
rsv
piv
hbov
south
african
studi
hospit
children
respiratori
diseas
higher
hrv
detect
rate
compar
healthi
children
vs
p
may
indic
causal
effect
hrv
diseas
kenya
older
children
year
old
despit
hrv
commonli
detect
viru
patient
present
ari
detect
rate
similar
among
asymptomat
control
inde
two
studi
kenya
found
except
rsv
viral
detect
nasopharynx
signific
associ
pneumonia
hospit
children
year
year
compar
children
without
symptom
urti
respiratori
symptom
meet
criteria
pneumonia
uncertain
impact
hiv
infect
durat
shed
virus
might
analysi
serial
respiratori
sampl
otherwis
healthi
children
detect
shed
day
hrv
day
hbov
day
detect
respiratori
specimen
transplant
children
also
report
least
day
week
respect
possibl
suggest
immunocompromis
children
may
prolong
durat
shed
virus
prolong
shed
immunocompromis
individu
hivinfect
children
may
result
greater
frequenc
coincident
identif
virus
investig
respiratori
ill
affect
season
occurr
virus
well
potenti
present
threat
greater
nosocomi
transmiss
virus
higher
incid
hospit
hivinfect
children
casual
relationship
viral
dna
detect
develop
diseas
mix
infect
complex
case
hbov
serolog
studi
shown
presenc
viral
dna
respiratori
sampl
proof
acut
primari
infect
prolong
viral
shed
could
explan
viral
detect
high
rate
asymptomat
control
enrol
healthi
nonhospit
children
quantif
viral
load
may
help
elucid
problem
coinfect
current
undertaken
multicentr
studi
aetiolog
pneumonia
children
contradictori
find
whether
infect
multipl
virus
contribut
diseas
sever
hospit
children
report
studi
report
increas
sever
among
children
viral
coinfect
other
find
decreas
sever
associ
coinfect
studi
differ
observ
found
multipl
viral
infect
associ
bronchial
breath
hivinfect
children
cyanosi
wheez
hivuninfect
children
bacteri
coinfect
also
increas
sever
viral
diseas
furthermor
children
invas
pneumococc
diseas
superimpos
viral
coinfect
common
may
lead
higher
mortal
rate
particip
studi
bacteri
cultur
perform
differ
clinic
laboratori
characterist
observ
children
without
viral
infect
analysi
howev
includ
vaccine
probabl
present
less
sever
lrti
case
sinc
shown
vaccin
associ
decreas
lrti
viralassoci
hospit
detect
high
preval
bacteri
coinfect
newlytest
virus
especi
hivinfect
children
may
contribut
higher
creactiv
protein
procalcitonin
level
longer
hospit
stay
higher
mortal
hivinfect
children
compar
hivuninfect
high
coinfect
detect
rate
similar
molecular
detect
studi
paediatr
respiratori
sampl
coronavirus
hbov
polyomavirus
result
may
howev
underestim
true
preval
viral
coinfect
sinc
previouslystudi
virus
test
immunofluoresc
convent
pcr
although
sensit
convent
method
report
high
compar
studi
shown
rtpcr
consider
sensit
detect
respiratori
virus
moreov
specimen
test
immunofluoresc
initi
screen
rsv
neg
test
influenza
b
piv
iiii
adenoviru
limit
studi
includ
posthoc
analysi
specimen
collect
studi
period
avail
test
compar
specimen
avail
rtpcr
specimen
unavail
collect
younger
children
like
test
posit
previouslystudi
viru
select
bia
may
also
contribut
underestim
number
coinfect
along
line
rsvassoci
lrti
common
among
younger
children
less
avail
sampl
increas
uncertainti
preval
rsv
coinfect
newlytest
virus
equal
proport
placeborecipi
hospit
lrti
investig
studi
analys
adjust
initi
intervent
arm
detail
analys
effect
incid
hospit
associ
individu
newlytest
virus
report
futur
although
develop
new
diagnost
techniqu
allow
detail
investig
led
discoveri
number
new
put
respiratori
pathogen
role
potenti
pathogen
respiratori
ill
remain
specul
absenc
fulfil
koch
postul
causal
present
studi
demonstr
least
one
respiratori
viru
identifi
major
hivinfect
hivuninfect
children
hospit
lrti
difficulti
attribut
diseas
causal
specif
virus
due
high
frequenc
viral
coinfect
suggest
possibl
synergi
among
differ
pathogen
childhood
lrti
tabl
primer
probe
sequenc
realtim
revers
transcriptasepolymeras
chain
reaction
viral
detect
use
studi
docx
